Advent Healthcare & Life Sciences III-A Limited Partnership

Advent Healthcare & Life Sciences III-A Limited Partnership is a declared insider of Aegerion Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 13 filings; the first trade dates from 27 October 2010 and the latest from 9 March 2012.

On the open market, the record shows 1 purchase worth €1.1M and 9 sales worth €2.2M. Taken together, the sales exceed the purchases by €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2012: no purchases and 4 sales on the market.

The record was last updated on 14 March 2012 with an open-market sale (€703k) in Aegerion Pharmaceuticals, Inc. The most recent open-market purchase was published on 27 October 2010, 5,857 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.